C4 Therapeutics (CCCC) Cash from Investing Activities Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -44.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.54% |
| Dec 31, 2025 | -690.59% |
| Sep 30, 2025 | 2,422.22% |
| Jun 30, 2025 | 432.49% |
| Mar 31, 2025 | 154.55% |
| Dec 31, 2024 | -57.21% |
| Sep 30, 2024 | -99.72% |
| Jun 30, 2024 | -177.28% |
| Mar 31, 2024 | -199.75% |
| Dec 31, 2023 | 244.09% |
| Sep 30, 2023 | 189.87% |
| Jun 30, 2023 | -54.41% |
| Mar 31, 2023 | 1,436.94% |
| Dec 31, 2022 | 115.63% |
| Sep 30, 2022 | 119.79% |
| Jun 30, 2022 | 2.45% |
| Mar 31, 2022 | 93.51% |
| Dec 31, 2021 | -9.68% |
| Sep 30, 2021 | -211.34% |
| Jun 30, 2021 | 131.24% |
| Mar 31, 2021 | -33,448.91% |
| Dec 31, 2020 | -27,257.07% |